antengene / 德琪医药

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: *

Meta Tags

Title	德琪医药
Description	医者无疆 Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative
Keywords	Antengene Corp

Server Information

WebSite	antengene.com
Host IP	47.89.186.36
Location	Canada

Related Websites

                        Site
                        Rank
                    

More to Explore

antengene.com Valuation

US$5,659,907

Last updated: 2023-05-01 05:24:24

antengene.com has Semrush global rank of 1,870,049. antengene.com has an estimated worth of US$ 5,659,907, based on its estimated Ads revenue. antengene.com receives approximately 653,067 unique visitors each day. Its web server is located in Canada, with IP address 47.89.186.36. According to SiteAdvisor, antengene.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$5,659,907
Daily Ads Revenue	US$5,225
Monthly Ads Revenue	US$156,736
Yearly Ads Revenue	US$1,880,831
Daily Unique Visitors	43,538
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
antengene.com.	A	1798	IP: 47.89.186.36
antengene.com.	NS	1800	NS Record: dns1.registrar-servers.com.
antengene.com.	NS	1800	NS Record: dns2.registrar-servers.com.
antengene.com.	MX	1799	MX Record: 0 antengene-com.mail.protection.partner.outlook.cn.
antengene.com.	TXT	1799	TXT Record: v=spf1 include:spf.protection.partner.outlook.cn -all
antengene.com.	TXT	1799	TXT Record: MS=AC9C622FADFF4FDAE45F53A3870ECF86C0ABF86A
antengene.com.	TXT	1799	TXT Record: MS=ms58886089

HtmlToTextCheckTime:2023-05-01 05:24:24

关于德琪公司概览愿景与使命全球运营布局领导团队企业社会责任联系我们公司业务药物发现临床开发药品生产商业化研究开发在研产品管线正在进行的部分临床试验科学论文及报告产品中心希维奥®/塞利尼索片新闻中心公司新闻媒体报道加入我们社会招聘校园招聘投资者关系中｜ EN 投资者关系中 EN 医者无疆创新永续 Treating Patients Beyond Borders 了解更多 Apr 27, 2023 德琪医药将于ASCO 2023上以壁报讨论形式公布mTORC1/2抑制剂ATG-008的最新TORCH-2研究成果了解更多 Apr 20, 2023 德琪医药合作伙伴Karyopharm在AACR 2023大会上公布塞利尼索治疗初治骨髓纤维化患者的最新数据了解更多 Apr 17, 2023 德琪医药再携五项研究成果亮相AACR 2023年会了解更多肿瘤治疗为核心 9 款临床阶段创新产品 3 个自主研发中心 2 个产业化基地 1 款药物 13国和地区上市 --> 研究开发 ASSETS "合作引进+自主研发" 双引擎研发战略全球科学合作伙伴 6 研发人员占比 38% 每年递交全新分子实体药物临床试验申请 *数据统计截止至2023年3月31日 2-3 在研产品管线了解更多进行中的临床试验了解更多科学论文及报告了解更多上市产品 THERAPIES 全球首个全新机制的口服选择性核输出蛋白抑制剂 --> 国家和地区获批上市 13 个相关治疗方案获得全球多个指南和循证研究的重磅推荐 27 项疾病领域了解更多药物机制了解更多学术文章了解更多关于德琪 GENERAL INFORMATION 聚焦突破性疗法，布局早期研发、临床研究、药物生产和商业化为一体的全产业链，以快速推进全球优质药物实现临床应用，惠及广大患者。 --> 加入我们在德琪，我们和来自世界各地最优秀的专家、行业精英以及最尖端的生物制药伙伴一起合作，为全球肿瘤患者带来最合适最先进的药物。公司发展了解更多公司业务了解更多领导团队了解更多关于德琪公司概览愿景与使命全球运营布局领导团队企业社会责任联系我们公司业务药物发现临床开发药品生产商业化研究开发

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Sat, 23 Oct 2021 21:32:23 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Location: https://antengene.com/
Strict-Transport-Security: max-age=31536000

HTTP/2 302 
server: nginx
date: Sat, 23 Oct 2021 21:32:23 GMT
content-type: text/html; charset=UTF-8
location: https://www.antengene.com/
strict-transport-security: max-age=31536000

HTTP/2 200 
server: nginx
date: Sat, 23 Oct 2021 21:32:23 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
vary: Accept-Encoding, Cookie
link: ; rel="https://api.w.org/"
strict-transport-security: max-age=31536000

antengene.com Whois Information

Domain Name: ANTENGENE.COM
Registry Domain ID: 1990757573_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.namecheap.com
Registrar URL: http://www.namecheap.com
Updated Date: 2021-01-27T03:18:49Z
Creation Date: 2015-12-31T03:03:17Z
Registry Expiry Date: 2030-12-31T03:03:17Z
Registrar: NameCheap, Inc.
Registrar IANA ID: 1068
Registrar Abuse Contact Email: abuse@namecheap.com
Registrar Abuse Contact Phone: +1.6613102107
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: DNS1.REGISTRAR-SERVERS.COM
Name Server: DNS2.REGISTRAR-SERVERS.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-12T06:53:38Z <<<

antengene.com valuation and analysis